Literature DB >> 9754566

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes.

I H Frazer1, G J Fernando, N Fowler, G R Leggatt, P F Lambert, A Liem, K Malcolm, R W Tindle.   

Abstract

When expressed as a transgene from the keratin 14 (K14) promoter in an MHC class II-deficient mouse, I-Ab expressed in thymic cortical epithelium promotes positive but not negative selection of I-Ab-restricted CD4+ T cells (Laufer, T. M. et al., Nature 1996. 383:81-85). Transgenic mice expressing the E7 protein of human papilloma virus 16 from the K14 promoter were studied to determine the consequence of expression of a cytoplasmic/ nuclear protein from the K14 promoter. K14E7-transgenic mice express E7 in the thymus and skin without evidence for autoimmunity to E7. Repeated immunization of FVB(H-2q) or F1(C57BL/6JxFVB) mice with E7 elicited similar antibody responses to the defined B cell epitopes of E7 in K14E7-transgenic and non-transgenic animals. In contrast, for each genetic background, a single immunization with E7 elicited demonstrable T cell proliferative responses to the major promiscuous T helper epitope of E7 in the transgenic but not the non-transgenic animals. Further, E7-immunized non-transgenic F1 (FVBxC57BL/6J) animals developed strong E7-specific cytotoxic T lymphocyte (CTL) responses and were protected against challenge with E7+ tumors, whereas similarly immunized K14E7-transgenic animals had a markedly reduced CTL response to E7 and no E7-specific tumor protection was observed, although the antibody and CTL response to ovalbumin was normal. Expression of E7 protein as a transgene from the K14 promoter in the skin and thymus thus induces E7-specific tolerance in the cytotoxic T effector repertoire, together with expansion of the E7-specific T helper repertoire. These findings demonstrate that limited tissue distribution of an autoantigen may result in "split" tolerance to that autoantigen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754566     DOI: 10.1002/(SICI)1521-4141(199809)28:09<2791::AID-IMMU2791>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.

Authors:  Nicholas C Souders; Duane A Sewell; Zhen-Kun Pan; S Farzana Hussain; Alexander Rodriguez; Anu Wallecha; Yvonne Paterson
Journal:  Cancer Immun       Date:  2007-02-06

2.  Antigen presentation by keratinocytes directs autoimmune skin disease.

Authors:  Lian Fan; Brian W Busser; Traci Q Lifsted; Mohamed Oukka; David Lo; Terri M Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Validation of an HPV16-mediated carcinogenesis mouse model.

Authors:  Katherine De Azambuja; Provabati Barman; Joy Toyama; David Elashoff; Gregory W Lawson; Lisa K Williams; Kristofer Chua; Deborah Lee; Joseph J Kehoe; Andre Brodkorb; Rebecca Schwiebert; Scott Kitchen; Aamir Bhimani; Dorothy J Wiley
Journal:  In Vivo       Date:  2014 Sep-Oct       Impact factor: 2.155

4.  Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles.

Authors:  T Doan; K Herd; M Street; G Bryson; G Fernando; P Lambert; R Tindle
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.

Authors:  R W Tindle; K Herd; T Doan; G Bryson; G R Leggatt; P Lambert; I H Frazer; M Street
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions.

Authors:  Masafumi Tauchi; Azumi Hida; Takaaki Negishi; Fumiki Katsuoka; Shuhei Noda; Junsei Mimura; Tomonori Hosoya; Akinori Yanaka; Hiroyuki Aburatani; Yoshiaki Fujii-Kuriyama; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.

Authors:  Adam E Snook; Michael S Magee; Stephanie Schulz; Scott A Waldman
Journal:  Eur J Immunol       Date:  2014-05-21       Impact factor: 5.532

Review 8.  Development of therapeutic HPV vaccines.

Authors:  Cornelia L Trimble; Ian H Frazer
Journal:  Lancet Oncol       Date:  2009-10       Impact factor: 41.316

9.  IL-18, but not IL-12, induces production of IFN-γ in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin.

Authors:  Stephen R Mattarollo; Antje Blumenthal; Christina Gosmann; Ian H Frazer
Journal:  J Invest Dermatol       Date:  2014-04-22       Impact factor: 8.551

10.  TSCOT+ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation.

Authors:  Sejin Ahn; Gwanghee Lee; Soo Jung Yang; Deokjae Lee; Seunghyuk Lee; Hyo Sun Shin; Min Cheol Kim; Kee Nyung Lee; Douglas C Palmer; Marc R Theoret; Eric J Jenkinson; Graham Anderson; Nicholas P Restifo; Moon Gyo Kim
Journal:  PLoS Biol       Date:  2008-08-05       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.